Goldman Sachs’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-10,824
| Closed | -$101K | – | 5035 |
|
|
2024
Q2 | $101K | Buy |
10,824
+9,389
| +654% | +$87.2K | ﹤0.01% | 4500 |
|
|
2024
Q1 | $47K | Sell |
1,435
-4,395
| -75% | -$144K | ﹤0.01% | 4544 |
|
|
2023
Q4 | $156K | Buy |
5,830
+2,084
| +56% | +$55.7K | ﹤0.01% | 4389 |
|
|
2023
Q3 | $227K | Sell |
3,746
-4,194
| -53% | -$254K | ﹤0.01% | 4210 |
|
|
2023
Q2 | $809K | Sell |
7,940
-494
| -6% | -$50.3K | ﹤0.01% | 3737 |
|
|
2023
Q1 | $1.49M | Buy |
8,434
+225
| +3% | +$39.8K | ﹤0.01% | 3401 |
|
|
2022
Q4 | $3.17M | Buy |
8,209
+827
| +11% | +$320K | ﹤0.01% | 2963 |
|
|
2022
Q3 | $2.49M | Buy |
7,382
+3,345
| +83% | +$1.13M | ﹤0.01% | 3199 |
|
|
2022
Q2 | $1.33M | Buy |
4,037
+483
| +14% | +$159K | ﹤0.01% | 3757 |
|
|
2022
Q1 | $1.56M | Buy |
3,554
+53
| +2% | +$23.2K | ﹤0.01% | 3758 |
|
|
2021
Q4 | $1.54M | Sell |
3,501
-5,027
| -59% | -$2.2M | ﹤0.01% | 3689 |
|
|
2021
Q3 | $4.74M | Sell |
8,528
-2,009
| -19% | -$1.12M | ﹤0.01% | 2833 |
|
|
2021
Q2 | $5.41M | Sell |
10,537
-1,768
| -14% | -$908K | ﹤0.01% | 2732 |
|
|
2021
Q1 | $9.62M | Sell |
12,305
-4,388
| -26% | -$3.43M | ﹤0.01% | 2233 |
|
|
2020
Q4 | $9.09M | Sell |
16,693
-406
| -2% | -$221K | ﹤0.01% | 2117 |
|
|
2020
Q3 | $7.83M | Buy |
17,099
+8,122
| +90% | +$3.72M | ﹤0.01% | 2105 |
|
|
2020
Q2 | $5.53M | Buy |
8,977
+3,082
| +52% | +$1.9M | ﹤0.01% | 2285 |
|
|
2020
Q1 | $2.8M | Sell |
5,895
-1,118
| -16% | -$532K | ﹤0.01% | 2580 |
|
|
2019
Q4 | $4.07M | Sell |
7,013
-1,338
| -16% | -$776K | ﹤0.01% | 2553 |
|
|
2019
Q3 | $5.5M | Buy |
8,351
+5,864
| +236% | +$3.86M | ﹤0.01% | 2265 |
|
|
2019
Q2 | $1.93M | Buy |
2,487
+897
| +56% | +$694K | ﹤0.01% | 2842 |
|
|
2019
Q1 | $1.12M | Sell |
1,590
-1,045
| -40% | -$738K | ﹤0.01% | 3208 |
|
|
2018
Q4 | $1.23M | Sell |
2,635
-1,797
| -41% | -$841K | ﹤0.01% | 3041 |
|
|
2018
Q3 | $3.82M | Sell |
4,432
-1,454
| -25% | -$1.25M | ﹤0.01% | 2572 |
|
|
2018
Q2 | $4.06M | Buy |
5,886
+5,050
| +604% | +$3.48M | ﹤0.01% | 2506 |
|
|
2018
Q1 | $372K | Sell |
836
-1,353
| -62% | -$602K | ﹤0.01% | 3619 |
|
|
2017
Q4 | $964K | Buy |
2,189
+1,285
| +142% | +$566K | ﹤0.01% | 3173 |
|
|
2017
Q3 | $446K | Sell |
904
-1,449
| -62% | -$715K | ﹤0.01% | 3559 |
|
|
2017
Q2 | $1.3M | Buy |
2,353
+2,026
| +620% | +$1.12M | ﹤0.01% | 3025 |
|
|
2017
Q1 | $216K | Sell |
327
-516
| -61% | -$341K | ﹤0.01% | 3925 |
|
|
2016
Q4 | $282K | Buy |
843
+74
| +10% | +$24.8K | ﹤0.01% | 3743 |
|
|
2016
Q3 | $231K | Sell |
769
-13
| -2% | -$3.91K | ﹤0.01% | 3841 |
|
|
2016
Q2 | $135K | Buy |
782
+430
| +122% | +$74.2K | ﹤0.01% | 4023 |
|
|
2016
Q1 | $79K | Buy |
+352
| New | +$79K | ﹤0.01% | 4102 |
|